Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-08-06
2010-02-09
Carlson, Karen Cochrane (Department: 1656)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C536S023100, C530S350000, C435S320100
Reexamination Certificate
active
07659092
ABSTRACT:
A single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent; a Targeting Moiety that is capable of binding to a Binding Site on the nociceptive sensory afferent, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the nociceptive sensory afferent; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the nociceptive sensory afferent. Nucleic acid sequences encoding the polypeptide fusion proteins, methods of preparing same and uses thereof are also described.
REFERENCES:
patent: 5668255 (1997-09-01), Murphy
patent: 5989545 (1999-11-01), Foster et al.
patent: 6395513 (2002-05-01), Foster
patent: 6461617 (2002-10-01), Shone
patent: 6632440 (2003-10-01), Quinn
patent: 6843998 (2005-01-01), Steward
patent: 6962703 (2005-11-01), Foster
patent: 7052702 (2006-05-01), Duggan
patent: 7056729 (2006-06-01), Donovan
patent: 7132259 (2006-11-01), Dolly
patent: 7192596 (2007-03-01), Shone
patent: 7208466 (2007-04-01), Foster
patent: 7244436 (2007-07-01), Donovan
patent: 7244437 (2007-07-01), Donovan
patent: 7262291 (2007-08-01), Donovan
patent: 7452543 (2008-11-01), Chaddock
patent: 2003/0049264 (2003-03-01), Foster et al.
patent: 2003/0180289 (2003-09-01), Foster
patent: 2004/0071736 (2004-04-01), Quinn
patent: 2005/0244435 (2005-11-01), Shone
patent: 2006/0051356 (2006-03-01), Foster
patent: 2006/0110410 (2006-05-01), Shone
patent: 2006/0216283 (2006-09-01), Foster
patent: 2007/0010447 (2007-01-01), Quinn
patent: 2007/0184048 (2007-08-01), Foster
patent: 2007/0184070 (2007-08-01), Shone
patent: 2007/0248626 (2007-10-01), Shone
patent: 2008/0032928 (2008-02-01), Quinn
patent: 2008/0038274 (2008-02-01), Foster
patent: 2008/0070278 (2008-03-01), North
patent: 1 422 240 (2004-05-01), None
patent: WO 96/33273 (1996-10-01), None
patent: 98/07864 (1998-02-01), None
patent: 99/17806 (1999-04-01), None
patent: WO 00/57897 (2000-10-01), None
patent: 01/14570 (2001-03-01), None
patent: 02/07759 (2002-01-01), None
patent: 2004/024909 (2004-03-01), None
patent: 2005/023309 (2005-03-01), None
patent: WO 2006/059113 (2006-06-01), None
U.S. Appl. No. 11/798,610, Quinn.
U.S. Appl. No. 08/513,878, filed Dec. 1, 1995, North.
U.S. Appl. No. 09/572,431, filed May 17, 2000, North.
U.S. Appl. No. 11/819,648, filed Jun. 28, 2007, Foster.
Okada et al.,Biochem. Biophys. Res. Comm. 278 :493-498 (2000).
Aoki Kei Roger
Chaddock John
Foster Keith
Francis Joseph
Marks Philip
Allergan Inc.
Carlson Karen Cochrane
Syntaxin Ltd.
LandOfFree
Fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152216